News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Epstein-Barr virus and brain cross-reactivity, a possible MS mechanism

junio 10, 2024

The common virus’ link with MS is likely to be caused by greater amounts of immune system ‘misdirection’ than previously thought.
Learn more

Study identifies mechanisms for selective MS treatment strategy

junio 07, 2024

Researchers stopped inflammatory signaling and immune response in lab samples.
Learn more

B cells drive responses of other immune cells, may potentially prevent MS symptoms

mayo 22, 2024

Abnormally active B cell metabolism causes an inflammatory immune response in individuals with MS.
Learn more

Molecule shows early-stage promise for myelin sheath repair

mayo 06, 2024

The discovery reveals a potential treatment for MS
Learn more

PET scans reveal ‘smoldering’ inflammation in patients with MS

abril 25, 2024

The new technique could lead to more advanced MS treatments.
Learn more

Study shows potential of subcutaneous injection Ocrevus as treatment option for relapsing, progressive MS

abril 23, 2024

Additional data showed the safety profile of Ocrevus SC injection was consistent with the well-established safety profile of Ocrevus IV infusion.
Learn more

MS signs may show up in blood years before symptoms

abril 22, 2024

But the researchers believe they now have a definitive sign that MS is brewing. 
Learn more

Study: Early Kesimpta treatment benefits people recently diagnosed with relapsing MS

abril 18, 2024

A separate analysis of the overall study population showed similar efficacy with continuous Kesimpta treatment, which was also well-tolerated with a consistent safety profile for up to six years.
Learn more

New study probes link between Epstein Barr, MS treatments

abril 09, 2024

Their findings have implications for future basic research in further understanding the biology of Epstein Barr Virus in multiple sclerosis.
Learn more

Epstein-Barr virus and brain cross-reactivity, a possible MS mechanism

junio 10, 2024

The common virus’ link with MS is likely to be caused by greater amounts of immune system ‘misdirection’ than previously thought.
Learn more

Study identifies mechanisms for selective MS treatment strategy

junio 07, 2024

Researchers stopped inflammatory signaling and immune response in lab samples.
Learn more

B cells drive responses of other immune cells, may potentially prevent MS symptoms

mayo 22, 2024

Abnormally active B cell metabolism causes an inflammatory immune response in individuals with MS.
Learn more

Molecule shows early-stage promise for myelin sheath repair

mayo 06, 2024

The discovery reveals a potential treatment for MS
Learn more

PET scans reveal ‘smoldering’ inflammation in patients with MS

abril 25, 2024

The new technique could lead to more advanced MS treatments.
Learn more

Study shows potential of subcutaneous injection Ocrevus as treatment option for relapsing, progressive MS

abril 23, 2024

Additional data showed the safety profile of Ocrevus SC injection was consistent with the well-established safety profile of Ocrevus IV infusion.
Learn more

MS signs may show up in blood years before symptoms

abril 22, 2024

But the researchers believe they now have a definitive sign that MS is brewing. 
Learn more

Study: Early Kesimpta treatment benefits people recently diagnosed with relapsing MS

abril 18, 2024

A separate analysis of the overall study population showed similar efficacy with continuous Kesimpta treatment, which was also well-tolerated with a consistent safety profile for up to six years.
Learn more

New study probes link between Epstein Barr, MS treatments

abril 09, 2024

Their findings have implications for future basic research in further understanding the biology of Epstein Barr Virus in multiple sclerosis.
Learn more

Childhood obesity linked to higher risk of developing MS in early adulthood

abril 01, 2024

The researchers said that despite the limited follow-up time, their findings highlight obesity in childhood is linked to an increased susceptibility of early-onset MS more than two-fold.
Learn more

New technique maps out cellular architecture of lesions in MS

marzo 22, 2024

In the next step, the researchers want to use the same technique to analyze samples from more MS patients.
Learn more

Participants being sought for pilot study

marzo 15, 2024

This no-cost program is meant as an addition to any medical care that participants are currently receiving.
Learn more

MS drugs taken while breastfeeding may not affect child development

marzo 06, 2024

The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab, and ofatumumab.
Learn more

Shifting the perspective in spasticity in MS

marzo 04, 2024

Taking the patient viewpoint on diagnosis and treatment.
Learn more

Study offers insights into lesion formation in MS

febrero 28, 2024

Researchers found that microglia nodules are linked to more severe MS pathology.
Learn more

Biological tool provides understanding of the complexity of MS

febrero 13, 2024

New study provides an integrated view of this complex system and revealed the relationship between four biological scales: proteins, cells, tissues, and behavior.
Learn more

Highly effective therapies linked to lower risk of relapse in pediatric-onset MS

febrero 09, 2024

The results suggest prioritizing initial highly effective therapies in pediatric onset MS, although long-term safety studies are needed.
Learn more

Participants sought for survey about access to, affordability of MS treatment

febrero 07, 2024

The results of the survey will help the Multiple Sclerosis Foundation represent the needs of the MS community while advocating for access to, and affordability of, treatments.
Learn more


Show More News